What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Gene
His primary scientific interests are in Internal medicine, Cancer, Gastroenterology, Helicobacter pylori and Pathology.
All of his Internal medicine and Intestinal metaplasia, Gastritis, Atrophic gastritis, Odds ratio and Disease investigations are sub-components of the entire Internal medicine study.
His work in Cancer addresses issues such as Oncology, which are connected to fields such as Meta-analysis.
His biological study focuses on Chronic gastritis.
His Helicobacter pylori research incorporates elements of CagA, Socioeconomic status, Immunology and Microbiology.
His studies in Pathology integrate themes in fields like Carcinogenesis and Stomach, Gastric mucosa.
His most cited work include:
- Classification and grading of gastritis.The updated Sydney system (4057 citations)
- Human Gastric Carcinogenesis: A Multistep and Multifactorial Process—First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention (2366 citations)
- Dysplasia in inflammatory bowel disease: Standardized classification with provisional clinical applications (1555 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Internal medicine, Cancer, Helicobacter pylori, Gastroenterology and Pathology.
Pelayo Correa frequently studies issues relating to Oncology and Internal medicine.
His Cancer study integrates concerns from other disciplines, such as Odds ratio, Epidemiology, Incidence, Surgery and Risk factor.
His Odds ratio research integrates issues from Case-control study and Confidence interval.
His Helicobacter pylori research is multidisciplinary, incorporating elements of CagA, Immunology, Gastric mucosa and Microbiology.
Chronic gastritis and Stomach cancer are among the areas of Gastroenterology where the researcher is concentrating his efforts.
He most often published in these fields:
- Internal medicine (43.89%)
- Cancer (33.73%)
- Helicobacter pylori (32.87%)
What were the highlights of his more recent work (between 2011-2021)?
- Helicobacter pylori (32.87%)
- Cancer (33.73%)
- Internal medicine (43.89%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Helicobacter pylori, Cancer, Internal medicine, Immunology and Cancer research.
His biological study spans a wide range of topics, including CagA, Carcinogenesis, Microbiology, Gastric mucosa and Serology.
His Cancer study combines topics in areas such as Odds ratio, Epidemiology, Surgery, Case-control study and Risk factor.
Pelayo Correa combines subjects such as Gastroenterology and Oncology with his study of Internal medicine.
Pelayo Correa works on Gastroenterology which deals in particular with Intestinal metaplasia.
The various areas that Pelayo Correa examines in his Immunology study include Helicobacter pylori infection and Stomach.
Between 2011 and 2021, his most popular works were:
- The gastric precancerous cascade (292 citations)
- Gastric cancer: overview. (193 citations)
- Human and Helicobacter pylori coevolution shapes the risk of gastric disease. (151 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
Pelayo Correa mainly investigates Helicobacter pylori, Cancer, CagA, Internal medicine and Immunology.
His research integrates issues of Carcinogenesis, Cancer research, Gastric mucosa and Microbiology in his study of Helicobacter pylori.
His Cancer research is multidisciplinary, relying on both Epidemiology, Incidence, Meta-analysis, Disease cluster and Public health.
His CagA research includes elements of Molecular biology, Downregulation and upregulation, Sequence analysis and Promoter.
Internal medicine is closely attributed to Gastroenterology in his work.
He interconnects Genotype and Risk factor in the investigation of issues within Immunology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
